Putnam, CT – (April 21, 2022) – Foster Corporation’s Distribution business, a leader in material solutions for the critical application healthcare market segment, has been appointed as the marketing partner for Porex Virtek® sintered PTFE membrane technology for the North American Healthcare Market effective April 11, 2022. Foster Distribution will provide the sales, technical support, and order fulfillment support for Porex Virtek® membrane technology through its locations in Connecticut and Nevada.
Porex Virtek® sintered PTFE membrane technology are high performance hydrophobic “medical grade” products that feature robust and durable performance, customizable membrane options, manufacturing and customization in a cleanroom, biocompatibility certification to USP Class VI, as well as being PFOA free. The membrane is a “clean white” color and is available in six different product configurations differentiated by airflow, ingress resistance, and membrane thickness. Customization options include cutting rolls to length, slitting to width down to 0.5 inches, and die cutting.
“Foster Distribution is dedicated to meeting the needs of our medical customers, and working with Porex with their Porex Virtek® membrane technology allows us extend our reach to customers with a new downstream product said Larry Johnson, President Foster Distribution. “While this type of product is out of the ordinary for Foster in terms of our identity as a medical compounder/distributor of pellet-based products, it is a great fit for our technical/value selling approach” and fills a need for many of our current customers.
For more information about Porex Virtek® sintered membrane technology in the healthcare market please contact our Foster Sales Team on our website at www.fosterpolymers.com.
*Virtek is a registered trademark of Porex Corporation
About Foster Corporation
For over thirty years Foster Corporation has been serving medical device manufacturers with industry leading technology and service in biomedical materials. These include custom medical compounds, implantable materials, and polymer distribution. Within ISO 13485:2016 facilities, Foster offers comprehensive support to customers from formulation development through production.
About Porex Corporation
For over 60 years, Porex Corporation, a business of Filtration Group, has been a major partner to customers in over 65 countries to deliver design innovations that turn product ideas into reality. Through a collaborative engineering partnership, Porex develops high-value porous polymer solutions to product design challenges in reflectivity, absorption, application, diffusion, filtration, venting, and wicking. With unmatched engineering experience, stringent regulatory and quality standards, and extensive global footprint, POREX® products form the standard of material excellence to bring your next medical device to life – and create a safer, healthier and more productive world.